» Articles » PMID: 15558498

Regression Mapping of Association Between the Human Leukocyte Antigen Region and Graves Disease

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2004 Nov 24
PMID 15558498
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

The human leukocyte antigen class II genes DRB1, DQB1, and DQA1 are associated with Graves disease (GD), but, because of strong linkage disequilibrium within this region, the primary etiological variant(s) remains unknown. In the present study, 871 patients with GD and 621 control subjects were genotyped at the DRB1, DQB1, and DQA1 loci. All three loci were associated with GD (P=1.45 x 10(-12), P=3.20 x 10(-5), and P=9.26 x 10(-12), respectively). Stepwise logistic-regression analysis showed that the association could be explained by either DRB1 or DQA1 but not by DQB1. To extend previous results, the amino acid sequence of the exon 2-encoded peptide-binding domain of DRB1 was predicted for each subject, and, by use of logistic regression, each position was analyzed for association with GD. Of 102 amino acids, 70 were uninformative; of the remaining 32 amino acids, 13 were associated with GD (P values ranged from 2.20 x 10(-4) to 1.2 x 10(-12)). The strongest association was at position beta 74. This analysis is consistent with the possibility that position beta 74 of exon 2 of the DRB1 molecule may have a specific and central role in autoantigen presentation by DRB1 to T lymphocytes. However, we cannot yet exclude a primary role for DQA1 or for other polymorphisms that affect DRB1 function or expression.

Citing Articles

The genetics of Graves' disease.

Grixti L, Lane L, Pearce S Rev Endocr Metab Disord. 2023; 25(1):203-214.

PMID: 38108994 PMC: 10808215. DOI: 10.1007/s11154-023-09848-8.


Significance of HLA in Graves' disease and Graves' orbitopathy in Asian and Caucasian populations - a systematic review.

Stasiak M, Stasiak B, Zawadzka-Starczewska K, Lewinski A Front Immunol. 2023; 14:1256922.

PMID: 37841270 PMC: 10568027. DOI: 10.3389/fimmu.2023.1256922.


Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and the gut.

Berryman M, Ilonen J, Triplett E, Ludvigsson J Front Immunol. 2023; 14:1270488.

PMID: 37828987 PMC: 10566625. DOI: 10.3389/fimmu.2023.1270488.


Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms.

de Filette J, Andre S, De Mey L, Aspeslagh S, Karmali R, Van der Auwera B BMC Endocr Disord. 2022; 22(1):291.

PMID: 36419114 PMC: 9682778. DOI: 10.1186/s12902-022-01190-5.


Evolution of Graves' Disease during Immune Reconstitution following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in a Boy Carrying Germline and Variants.

Ip P, Fang L, Shen Y, Tung K, Lai M, Juan L Int J Mol Sci. 2022; 23(16).

PMID: 36012751 PMC: 9409095. DOI: 10.3390/ijms23169494.


References
1.
Tomer Y, Barbesino G, Greenberg D, Concepcion E, Davies T . Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab. 1999; 84(12):4656-64. DOI: 10.1210/jcem.84.12.6216. View

2.
Gough S . The genetics of Graves' disease. Endocrinol Metab Clin North Am. 2000; 29(2):255-66. DOI: 10.1016/s0889-8529(05)70130-4. View

3.
Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K . Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet. 2001; 10(13):1379-86. DOI: 10.1093/hmg/10.13.1379. View

4.
Cucca F, Lampis R, Congia M, Angius E, Nutland S, Bain S . A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum Mol Genet. 2001; 10(19):2025-37. DOI: 10.1093/hmg/10.19.2025. View

5.
Cordell H, Clayton D . A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet. 2001; 70(1):124-41. PMC: 384883. DOI: 10.1086/338007. View